Insmed
INSM
#1050
Rank
โ‚น2.232 T
Marketcap
โ‚น10,298
Share price
-1.82%
Change (1 day)
15.82%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚น97.89 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น0.81 Billion. In 2025 the company made an earning of -โ‚น115.33 Billion a decrease over its 2024 earnings that were of -โ‚น80.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น97.89 Billion-15.12%
2025 -โ‚น115.33 Billion43.91%
2024 -โ‚น80.14 Billion23.71%
2023 -โ‚น64.78 Billion45.77%
2022 -โ‚น44.44 Billion15.83%
2021 -โ‚น38.37 Billion50.19%
2020 -โ‚น25.55 Billion16.4%
2019 -โ‚น21.95 Billion-23.9%
2018 -โ‚น28.84 Billion59.35%
2017 -โ‚น18.1 Billion8.52%
2016 -โ‚น16.68 Billion47.25%
2015 -โ‚น11.33 Billion34.53%
2014 -โ‚น8.42 Billion58.83%
2013 -โ‚น5.3 Billion35.14%
2012 -โ‚น3.93 Billion-31.92%
2011 -โ‚น5.77 Billion854.92%
2010 -โ‚น0.61 Billion-105.22%
2009 โ‚น11.55 B-905.06%
2008 -โ‚น1.44 Billion-27.31%
2007 -โ‚น1.98 Billion-62.41%
2006 -โ‚น5.26 Billion98.19%
2005 -โ‚น2.65 Billion0.03%
2004 -โ‚น2.65 Billion159.07%
2003 -โ‚น1.03 Billion-69.31%
2002 -โ‚น3.34 Billion
2000 -โ‚น3.01 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.524 T-1,532.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น1.036 T-1,073.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น488.84 B-559.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น2.36 B-102.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.25 Billion-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚น2.28 Billion-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA